Cargando…

P817: VALIDATION OF THE SECOND REVISED INTERNATIONAL STAGING SYSTEM (R2-ISS) IN A LARGE POPULATION-BASED, NATIONWIDE COHORT OF PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

Detalles Bibliográficos
Autores principales: Brieghel, Christian, Nørgaard Andersen, Morten, Grønne Jørgensen, Nicolai, Silkjær, Trine, Lund, Thomas, Hinge, Maja, Gregersen, Henrik, Schou Pedersen, Robert, Szabo, Agoston, Niemann, Carsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430582/
http://dx.doi.org/10.1097/01.HS9.0000970172.01814.d6
_version_ 1785090999983276032
author Brieghel, Christian
Nørgaard Andersen, Morten
Grønne Jørgensen, Nicolai
Silkjær, Trine
Lund, Thomas
Hinge, Maja
Gregersen, Henrik
Schou Pedersen, Robert
Szabo, Agoston
Niemann, Carsten
author_facet Brieghel, Christian
Nørgaard Andersen, Morten
Grønne Jørgensen, Nicolai
Silkjær, Trine
Lund, Thomas
Hinge, Maja
Gregersen, Henrik
Schou Pedersen, Robert
Szabo, Agoston
Niemann, Carsten
author_sort Brieghel, Christian
collection PubMed
description
format Online
Article
Text
id pubmed-10430582
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104305822023-08-17 P817: VALIDATION OF THE SECOND REVISED INTERNATIONAL STAGING SYSTEM (R2-ISS) IN A LARGE POPULATION-BASED, NATIONWIDE COHORT OF PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA Brieghel, Christian Nørgaard Andersen, Morten Grønne Jørgensen, Nicolai Silkjær, Trine Lund, Thomas Hinge, Maja Gregersen, Henrik Schou Pedersen, Robert Szabo, Agoston Niemann, Carsten Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430582/ http://dx.doi.org/10.1097/01.HS9.0000970172.01814.d6 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Brieghel, Christian
Nørgaard Andersen, Morten
Grønne Jørgensen, Nicolai
Silkjær, Trine
Lund, Thomas
Hinge, Maja
Gregersen, Henrik
Schou Pedersen, Robert
Szabo, Agoston
Niemann, Carsten
P817: VALIDATION OF THE SECOND REVISED INTERNATIONAL STAGING SYSTEM (R2-ISS) IN A LARGE POPULATION-BASED, NATIONWIDE COHORT OF PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
title P817: VALIDATION OF THE SECOND REVISED INTERNATIONAL STAGING SYSTEM (R2-ISS) IN A LARGE POPULATION-BASED, NATIONWIDE COHORT OF PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
title_full P817: VALIDATION OF THE SECOND REVISED INTERNATIONAL STAGING SYSTEM (R2-ISS) IN A LARGE POPULATION-BASED, NATIONWIDE COHORT OF PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
title_fullStr P817: VALIDATION OF THE SECOND REVISED INTERNATIONAL STAGING SYSTEM (R2-ISS) IN A LARGE POPULATION-BASED, NATIONWIDE COHORT OF PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
title_full_unstemmed P817: VALIDATION OF THE SECOND REVISED INTERNATIONAL STAGING SYSTEM (R2-ISS) IN A LARGE POPULATION-BASED, NATIONWIDE COHORT OF PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
title_short P817: VALIDATION OF THE SECOND REVISED INTERNATIONAL STAGING SYSTEM (R2-ISS) IN A LARGE POPULATION-BASED, NATIONWIDE COHORT OF PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
title_sort p817: validation of the second revised international staging system (r2-iss) in a large population-based, nationwide cohort of patients with newly diagnosed multiple myeloma
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430582/
http://dx.doi.org/10.1097/01.HS9.0000970172.01814.d6
work_keys_str_mv AT brieghelchristian p817validationofthesecondrevisedinternationalstagingsystemr2issinalargepopulationbasednationwidecohortofpatientswithnewlydiagnosedmultiplemyeloma
AT nørgaardandersenmorten p817validationofthesecondrevisedinternationalstagingsystemr2issinalargepopulationbasednationwidecohortofpatientswithnewlydiagnosedmultiplemyeloma
AT grønnejørgensennicolai p817validationofthesecondrevisedinternationalstagingsystemr2issinalargepopulationbasednationwidecohortofpatientswithnewlydiagnosedmultiplemyeloma
AT silkjærtrine p817validationofthesecondrevisedinternationalstagingsystemr2issinalargepopulationbasednationwidecohortofpatientswithnewlydiagnosedmultiplemyeloma
AT lundthomas p817validationofthesecondrevisedinternationalstagingsystemr2issinalargepopulationbasednationwidecohortofpatientswithnewlydiagnosedmultiplemyeloma
AT hingemaja p817validationofthesecondrevisedinternationalstagingsystemr2issinalargepopulationbasednationwidecohortofpatientswithnewlydiagnosedmultiplemyeloma
AT gregersenhenrik p817validationofthesecondrevisedinternationalstagingsystemr2issinalargepopulationbasednationwidecohortofpatientswithnewlydiagnosedmultiplemyeloma
AT schoupedersenrobert p817validationofthesecondrevisedinternationalstagingsystemr2issinalargepopulationbasednationwidecohortofpatientswithnewlydiagnosedmultiplemyeloma
AT szaboagoston p817validationofthesecondrevisedinternationalstagingsystemr2issinalargepopulationbasednationwidecohortofpatientswithnewlydiagnosedmultiplemyeloma
AT niemanncarsten p817validationofthesecondrevisedinternationalstagingsystemr2issinalargepopulationbasednationwidecohortofpatientswithnewlydiagnosedmultiplemyeloma